Transcriptomic analysis revealed that dyslipidemia disrupts lipid metabolic homeostasis by disrupting rhythmic expression of core circadian clock genes (Clock, Per2, Per3) in meibomian glands, ultimately leading to gland dysfunction. The gene discussed is CLOCK; the disease is metabolic syndrome.